Eisai, Inc. has opened its newly constructed parenteral facility in Research Triangle Park (RTP), NC. The 65,000-sq.-ft. facility will serve as the company’s global commercial manufacturing and drug development site for intravenous drug products in support of global clinical development programs, including those for oncology. The $100 million facility encompasses aseptic processing suites, labs and other support functions. The new operation is also designed to handle and process highly potent co...